New EMCDDA Guidelines
What are the most effective treatment options for cannabis problems? How to respond to new trends in cocaine use? How to help prevent the non-medical use of medicines?
These are among the questions explored in a new collection of miniguides launched by the EU drugs agency (EMCDDA). The miniguides — being released in four successive bundles between October 2021 and early 2022 — focus on patterns of use, harms, settings and vulnerable groups. Together, they make up the agency’s latest overview of actions and interventions now available to respond to the consequences of illicit drug use.
Drawing on a fresh global review of the evidence, and insights from 29 countries (27 EU, Turkey and Norway), the miniguides are designed to support practitioners and policymakers in addressing the negative consequences of drug use. The resources are presented in a digital and modular format, designed to improve accessibility, to be easier to read across a range of devices and to facilitate regular updates and translations.
You can read more on the EMCDDA website here.